[Lyophilised vein as a vascular prosthesis].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 4340328)

Published in Thoraxchir Vask Chir on June 01, 1972

Authors

G Breitenecker, P Eichelter, M Staudacher, W Weissenhofer

Articles by these authors

(truncated to the top 100)

Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res (2000) 3.35

Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy. Clin Cancer Res (2001) 1.99

Fractal analysis: an objective method for identifying atypical nuclei in dysplastic lesions of the cervix uteri. Gynecol Oncol (1999) 1.74

Trends in vulvar neoplasia. Increasing incidence of vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women. J Reprod Med (2000) 1.66

Quantitative immunohistochemistry of factor VIII-related antigen in breast carcinoma: a comparison of computer-assisted image analysis with established counting methods. Am J Clin Pathol (1996) 1.60

Prophylaxis of pulmonary embolism. A new experimental appraoch with initial results. Arch Surg (1968) 1.51

Prolongation of pregnancy and survival of twin B after loss of twin A at 21 weeks' gestation. Am J Obstet Gynecol (1989) 1.39

[Human papillomavirus infections and carcinoembryonic antigen expression in cervix intra-epithelial neoplasia of intermediate grade]. Pathologe (1993) 1.37

Serum concentration of pregnancy-specific beta-1-glycoprotein (sp-1) in normal and pathologic pregnancies. Arch Gynakol (1974) 1.30

Lymphatic microvessel density as a novel prognostic factor in early-stage invasive cervical cancer. Int J Cancer (2001) 1.21

Selective immunohistochemical staining of blood and lymphatic vessels reveals independent prognostic influence of blood and lymphatic vessel invasion in early-stage cervical cancer. Clin Cancer Res (2001) 1.17

Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients. Br J Cancer (1999) 1.16

[Gangrene following erroneous intra-arterial injection of dicloxacillin]. Dtsch Med Wochenschr (1971) 1.08

Prevalence of self-reported cervical cancer screening and impact on cervical cancer mortality in Austria. Wien Klin Wochenschr (1999) 1.07

[Pregnancy-specific beta1-glycoprotein (sp-1): clinical aspects (author's transl)]. Wien Klin Wochenschr (1975) 1.04

Modified true-color computer-assisted image analysis versus subjective scoring of estrogen receptor expression in breast cancer: a comparison. Anticancer Res (1999) 1.03

Inflammatory stromal reaction correlates with lymphatic microvessel density in early-stage cervival cancer. Anticancer Res (2002) 1.01

Hemodynamics of pancreatic secretion. With observations on pancreatic oxygen consumption. Arch Surg (1966) 1.00

Diagnostic and therapeutic approaches to carotid body tumors. Review of 24 patients. Arch Surg (1997) 0.99

Small-cell carcinoma of the uterus and the vagina: experience with ten patients. Arch Gynecol Obstet (2004) 0.98

Embryonal rhabdomyosarcoma of the uterine cervix: case report and review of the literature. Gynecol Oncol (1998) 0.98

Evidence that immunosuppression is an intrinsic property of the alpha-fetoprotein molecule. Adv Exp Med Biol (1995) 0.97

Use of CA 125 monoclonal antibody to monitor patients with ovarian cancer. Gynecol Oncol (1989) 0.95

Prognostic value of tumour microvessel density in cancer of the uterine cervix stage IB to IIB. Anticancer Res (1995) 0.95

Prognostic value of CD44 splice variants in human stage III cervical cancer. Eur J Cancer (1995) 0.94

Fluorescence in situ hybridization in cervical smears: detection of numerical aberrations of chromosomes 7, 3, and X and relationship to HPV infection. Gynecol Oncol (1999) 0.93

The impact of expression of the metastasis suppressor protein KAI1 on prognosis in invasive squamous cell cervical cancer. Anticancer Res (2001) 0.92

[Reevaluation of cytological smears in patients with cervical cancer. Regional quality assurance program with the cooperation of the Austrian Society for Cytology, the Carinthian Medical Association and the Carinthian Ministry of Health]. Pathologe (2007) 0.92

Splice variants of CD44 in human cervical cancer stage IB to IIB. Gynecol Oncol (1995) 0.91

Cathepsin D in ovarian cancer: prognostic value and correlation with p53 expression and microvessel density. Gynecol Oncol (2004) 0.91

[The correlation between lh determination in the urine (Luteonosticon and JI-Gonavis) and serum LH, FSH, oestradiol, progesterone, testosterone and prolactin levels at midcycle. (author's transl)]. Wien Klin Wochenschr (1979) 0.91

Accuracy of intraoperative frozen-section diagnosis in stage I endometrial adenocarcinoma. Gynecol Obstet Invest (2000) 0.91

Premalignant and malignant uterine changes in immunosuppressed renal transplant recipients. Acta Obstet Gynecol Scand (1978) 0.90

Leiomyosarcoma of the vulva. A case report. J Reprod Med (2001) 0.90

Leiomyoma of the round ligament in a postmenopausal woman. Maturitas (1999) 0.90

Preperitoneal lipoleiomyoma of the abdominal wall in a postmenopausal woman. Maturitas (2000) 0.88

Turnover of amino acids in sepsis and starvation: Effect of glucose infusion. J Trauma (1976) 0.87

Tissue expression of CA 125 in benign and malignant lesions of ovary and fallopian tube: a comparison with CA 19-9 and CEA. Gynecol Oncol (1989) 0.87

Immunohistochemical expression of laminin-5 in cervical intraepithelial neoplasia. Gynecol Oncol (2003) 0.87

Signal-amplified colorimetric in situ hybridization for assessment of human papillomavirus infection in cervical lesions. Mod Pathol (2001) 0.86

Influence of microvessel density and vascular permeability factor/vascular endothelial growth factor expression on prognosis in vulvar cancer. Gynecol Oncol (1996) 0.86

[Temporary gastrostomy as an alternative procedure for nasogastric suction]. Chirurg (1976) 0.86

Lymphatic microvessel density in epithelial ovarian cancer: its impact on prognosis. Anticancer Res (2000) 0.86

Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7-8 in human breast cancer. Eur J Cancer (1996) 0.86

Prognostic value of beta1-integrin (=CD29) in serous adenocarcinomas of the ovary. Anticancer Res (2001) 0.86

Comparative evaluation of seven cell collection devices for cervical smears. Acta Cytol (1999) 0.85

Prognostic value of immunohistochemically detected HER-2/neu oncoprotein in endometrial cancer. Cancer Lett (1996) 0.84

Is high-risk human papillomavirus infection associated with cervical intraepithelial neoplasia eliminated after conization by large-loop excision of the transformation zone? Eur J Obstet Gynecol Reprod Biol (2001) 0.84

Angiogenesis in vulvar intraepithelial neoplasia. Gynecol Oncol (1997) 0.83

Lack of impact of platinum dose intensity on the outcome of ovarian cancer patients. 10-year results of a prospective randomised phase III study comparing carboplatin-cisplatin with cyclophosphamide-cisplatin. Eur J Cancer (2003) 0.83

Cervical neoplasia and human papilloma virus infection in prostitutes. Genitourin Med (1991) 0.83

The influence of vascular space involvement on the prognosis of patients with stage IB cervical carcinoma: correlation of results from hematoxylin and eosin staining with results from immunostaining for factor VIII-related antigen. Cancer (1998) 0.83

CD-44 is not involved in the metastatic spread of ovarian cancer in vivo. Anticancer Res (1996) 0.83

Immunohistochemical detection of estrogen and progesterone receptor in human cornea. Maturitas (2000) 0.82

[Immunohistochemical demonstration of CA 125, CA 19-9 and CEA in normal and pathologically changed adnexa]. Geburtshilfe Frauenheilkd (1988) 0.82

Diagnosis of cervical intraepithelial neoplasia and human papillomavirus infection: punch biopsy versus cervical smear. Arch Gynecol Obstet (1991) 0.82

[The clinical value of histoautoradiographic studies during radiotherapy of cervix carcinoma]. Strahlentherapie (1975) 0.82

Influence of postoperative treatment on survival in patients with uterine papillary serous carcinoma. Gynecol Oncol (1998) 0.81

Immunohistochemical detection of mutant p53-suppressor gene product in patients with breast cancer: influence on metastasis-free survival. Anticancer Res (1993) 0.81

Downregulation of KAI1 metastasis suppressor protein is associated with a dismal prognosis in epithelial ovarian cancer. Gynecol Oncol (2001) 0.81

The use of mesh-tube-constricted dilated or varicose veins as arterial bypass conduit. Thorac Cardiovasc Surg (1992) 0.81

[Carcinoma of the uterus in the Austrian mortality statistics. 1. Carcinoma of the uterus in Viennese autopsy reports 1976 (author's transl)]. Wien Klin Wochenschr (1979) 0.81

Prospective clinical study with in vitro endothelial cell lining of expanded polytetrafluoroethylene grafts in crural repeat reconstruction. J Vasc Surg (1992) 0.80

Progesterone, oestradiol-17 beta and testosterone levels in the follicular fluid of tertiary follicles and Graafian follicles of human ovaries. Acta Endocrinol (Copenh) (1975) 0.80

Partial long arm deletion of one X chromosome in a patient with secondary amenorrhea. Hum Genet (1979) 0.79

[The extra-anatomic bypass in the therapy of aortoiliacal occlusive disease]. Wien Klin Wochenschr (1989) 0.79

Prognostic value of cathepsin D expression and association with histomorphological subtypes in breast cancer. Br J Cancer (1998) 0.79

[On osteosynthesis of malleolar fractures]. Arch Orthop Unfallchir (1967) 0.79

Histopathology of experimental pancreatitis in the dog. With modification resulting from whole body hypothermia. Arch Surg (1966) 0.78

Oral contraceptives and human papillomavirus infection in cervical intraepithelial neoplasia. Arch Gynecol Obstet (1992) 0.78

[Defects in the prostaglandin system. II. Familial platelet-prostacyclin receptor defect (Wien-Hietzing defect)--pathogenetic significance for (early) development of atherosclerosis?]. Wien Klin Wochenschr (1985) 0.78

CA19-9, CA125 and CEA in endometrial carcinoma tissue and its relation to hormone receptor content and histological grading. Arch Gynecol Obstet (1988) 0.78

The prognostic value of CD44 isoform expression in endometrial cancer. Br J Cancer (1998) 0.78

[Total A-V block following blunt thoracic trauma]. Monatsschr Unfallheilkd Versicher Versorg Verkehrsmed (1972) 0.78

[Guidelines for diagnosis and therapy of intraepithelial neoplasia and early invasive carcinoma of the female lower genital system (cervix uteri, vagina, vulva) established by the AGK (Colposcopy Work Group in the OGGG [Austrian Society of Gynecology and Obstetrics])]. Gynakol Geburtshilfliche Rundsch (2001) 0.78

Impact of human papillomavirus infection on the expression of the KAI1 metastasis suppressor protein in invasive cervical cancer. Cancer Lett (2001) 0.78

Influence of counterpulsation on experimental acute cardiac failure. J Thorac Cardiovasc Surg (1966) 0.77

Mutant p53 in patients with invasive cervical cancer stages IB to IIB. Gynecol Oncol (1995) 0.77

Mutant p53 product in patients with stage III cervical cancer. Anticancer Res (1993) 0.77

Prognostic value of immunohistochemically detected p53 expression in vulvar carcinoma. Cancer (1995) 0.77

[Aneurysma spurium after iatrogenic arterial puncture--incidence, risk factors and surgical therapy]. Wien Klin Wochenschr (1993) 0.77

p53 protein overexpression: a strong prognostic factor in uterine papillary serous carcinoma. Gynecol Oncol (1998) 0.77

Incidence of cervical smears indicating dysplasia among Austrian women during the 1980s. Br J Obstet Gynaecol (1995) 0.77

The progesterone content of the fluid and the activity of the steroid-3beta-ol-dehydrogenase within the wall of the ovarian follicles. Acta Endocrinol (Copenh) (1974) 0.76

Prognostic significance of tumor angiogenesis in primary fallopian tube cancer. Cancer Lett (1999) 0.76

Immunohistochemical detection of adhesion molecule CD44 splice variants in lymph node metastases of cervical cancer. Int J Cancer (1996) 0.76

Absence of p53 protein overexpression in precancerous lesions of the vulva. Cancer (1998) 0.76

Recovery of intraoperatively shed blood in aortoiliac surgery: comparison of cell washing with simple filtration. Thorac Cardiovasc Surg (1995) 0.76

[Prognostic significance of morphological parameters in malignant epithelial ovarian tumors]. Pathologe (1983) 0.76

[Adjuvant hormone therapy in endometrial carcinoma: medroxyprogesterone acetate versus tamoxifen-medroxyprogesterone acetate sequential therapy]. Gynakol Rundsch (1990) 0.76

Correlations between endotoxin, interferon-gamma, biopterin and serum phospholipase A2-activities during lethal gram negative sepsis in rats. Eur J Surg (1997) 0.76

p53 protein overexpression in early stage endometrial cancer. Gynecol Oncol (1996) 0.76

Hybrid capture based human papillomavirus typing in cervical screening compared to cytology and histology. Wien Klin Wochenschr (2000) 0.76

Numerical chromosomal aberrations in borderline, benign, and malignant epithelial tumors of the ovary: correlation with p53 protein overexpression and Ki-67. J Soc Gynecol Investig (1998) 0.75

[Glomus caroticum chemodectoma. Review on current diagnosis and therapy]. Wien Klin Wochenschr (2000) 0.75

Mesh tube--constricted varicose veins used as bypass grafts for infrainguinal arterial reconstruction. Arch Surg (1992) 0.75

Influence of age and human papillomavirus-infection on reliability of cervical cytopathology. Arch Gynecol Obstet (1995) 0.75

CD44v3 and v6 variant isoform expression correlates with poor prognosis in early-stage vulvar cancer. Br J Cancer (1998) 0.75

When applied to facial skin, does estrogen ointment have systemic effects? Arch Gynecol Obstet (1993) 0.75

Lysosomal protease cathepsin D is a prognostic marker in endometrial cancer. Br J Cancer (1996) 0.75